Recombinant allergens: Application to diagnostic and therapeutic perspectives;Allergenes recombinants: Utilisation diagnostique et perspectives therapeutiques

Revue des Maladies Respiratoires

Volumn 17, Issue 1 BIS, 2000, Pages 293-303

  Pauli, G ^a   Deviller, P ^b  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b Univ Claude Bernard   (France)

Author keywords

Diagnostic allergy; Immunotherapy; Isoforms; Recombinants allergens

Indexed keywords

ALLERGEN; DIAGNOSTIC AGENT; RECOMBINANT PROTEIN;

ALLERGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; IMMUNOTHERAPY; PROVOCATION TEST; REVIEW; SENSITIZATION; SKIN TEST; HYPERSENSITIVITY; IMMUNOLOGY; RESPIRATORY TRACT ALLERGY;

ALLERGENS; HUMANS; HYPERSENSITIVITY; RECOMBINANT PROTEINS; RESPIRATORY HYPERSENSITIVITY;

EID: 0034135919     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. THOMAS WR, STEWART GA, SIMPSON RJ, CHUA KY et al. : Cloning and expression of DNA coding for the major house dust mite allergen Der p 1 in Escherichia coli. Int Arch Allergy Appl Immunol 1988;85:127-9.
2. BOUSQUET J, VALENTA R : In vivo and in vitro use of recombinant allergens. ACI News 1994;6:54-9.
3. VALENTA R, KRAFT D : Recombinant allergens for diagnosis and therapy of allergic diseases. Curr Opin Immunol 1995;7:751-6.
4. CHAPMAN MD, SMITH AM, VAILES LD, ARRUDA LK : Recombinant mite allergens. Allergy 1997;52:374-9.
5. FERREIRA F, MAYER P, SPERR WR et al. : Induction of IgE antibodies with predefined specificity in rhesus monkeys with recombinant birch pollen allergens, Bet v 1 and Bet v 2. J. Allergy Clin. Immunol 1996;97:95-103.
6. VRTALA S, MAYER P, FERREIRA F et al. : Induction of IgE antibodies in mice and rhesus monkeys with recombinant birch pollen allergens: different allergenicity of Bet v 1 and Bet v 2. J Allergy Clin Immunol 1996;98:913-21
7. VALENTA R, DUCHENE M, VRTALA S et al. : Recombinant allergens for immunoblot diagnosis of tree-pollen allergy. J. Allergy Clin. Immunol, 1991;88:889-94.
8. PAULI G, OSTER JP, DEVILLER P et al. : Skin testing with recombinant allergens rBet v 1 and birch profilin, rBet v 2: diagnostic value for birch pollen and associated allergies. J Allergy Clin Immunol 1996;97:1100-9.
9. MENZ G, DOLECEK C, SCHÖNHEIT-KENN U et al. : Serological and skin-test diagnosis of birch pollen allergy with recombinant Bet v I, the major birch pollen allergen. Clin Exp Allergy 1996;26:50-60.
10. ELFMAN L, SVENSSON M, LIDHOLM J, PAULI G, VALENTA R : Different profiles in specific IgE to rBet v 1 and rBet v 2 in patients allergic to birch pollen from six countries, Int Arch Allergy Immunol 1997;113:249-51.
11. Rossi RE., MONASTEROLO G, OPERTI D, CORSI M : Evaluation of recombinant allergens Bet v 1 and Bet v 2 (profilin) by Pharmacia CAP System in patients with pollen-related allergy to birch and apple. Allergy 1996;51:940-5.
12. GODNIC-CVAR J, SUSANI M, BREITENEDER H et al. : Recombinant Bet v 1, the major birch pollen allergen, induces hypersensitivity reactions equal to those induced by natural Bet v 1 in the airways of patients allergic to tree pollen. J Allergy Clin Immunol 1997;99:354-9.
13. VALENTA R, DUCHENE M, PETTENBURGER K et al. : Identification of profilin as novel pollen allergen: IgE auto-reactivity in sensitized patients. Science 1991;253:557-60.
14. VALENTA R, VRTALA S, EBNER C, KRAFT D, SCHEINER O : Diagnosis of grass pollen allergy with recombinant timothy grass (Phleum pratense) pollen allergens. Int Arch Allergy Immunol 1992;97:287-94.
15. LAFFER S, SPITZAUER S, SUSANI M et al. : Comparison of recombinant timothy grass pollen allergens with natural extract for diagnosis of grass pollen allergy in different populations. J Allergy Clin Immunol 1996;98:652-8.
16. GUERIN-MARCHAND C, SENECHAL H, BOUIN AP et al. : Cloning, sequencing and immunological characterization of Dac g 3, a major allergen from Dactylis glomerata pollen. Mol Immunol 1996;33:797-806.
17. ROBERTS AM, VAN REE R, CARDY SM, BEVAN LJ, WALKER MR : Recombinant pollen allergens from Dactylis glomerata: preliminary evidence that human IgE cross-reactivity between Dac g II and Lol p I/II is increased following grass pollen immunotherapy. Immunology 1992;76:389-96.
18. TAMBORINI E, BRANDAZZA A, DE LALLA C et al. : Recombinant allergen Lol p II: expression, purification and characterization. Mol Immunol 1995;32:505-13.
19. RAFNAR T, GRIFFITH IJ, KUO MC, BOND JF, ROGERS BL, KLAPPER DG : Cloning of Amb a I (antigen E), the major allergen familly of short ragweed pollen. J Biol Chem 1991;266:1229-36.
20. RAFNAR T, GHOSH B, METZLER WJ et al. : Expression and analysis of recombinant Amb a V and Amb t V allergens. Comparison with native proteins by immunological assays and NMR spectroscopy. J Biol Chem 1992;267:21119-23.
21. ROGERS BL, MORGENSTERN JP, GRIFFITH IJ et al. : Complete sequence of the allergen Amb a II. Recombinant expression and reactivity with T-cells from ragweed allergic patienls. J Immunol 1991;147:2547-52.
22. DURO G, COLOMBO P, COSTA MA, IZZO V et al. : cDNA cloning, sequence analysis and allergological characterization of Par j 2.0101, a new major allergen of the Parietaria judaica pollen. FEBS Letters 1996;3:295-8.
23. CHUA KY, KEHAL PK, THOMAS WR, VAUGHAN PR, MACREADIE IG : High-frequency binding of IgE to the Der p allergen expressed in yeast. J Allergy Clin Immunol 1992;89:95-102.
24. NOGUCHI E, SHIBASAKI M, NISHIYAMA C, OKUMURA Y, TAKITA H : IgE responsiveness to Dermatophagoides farinae in young asthmatic children: IgE binding study using recombinant allergens of Der f 1, Der f 2 and mutant proteins of Der f 2. Int Arch Allergy Immunol 1996;110:380-7.
25. CHUA KY, DILWORTH RJ, THOMAS WR : Expression of Dermatophagoïdes pteronyssinus allergen, Der p II, in Escherichia coli and the binding studies with human IgE. Int Arch Allergy Appl Immunol 1990;91:124-9.
26. LYNCH NR, THOMAS WR, CHUA Y, GARCIA N, DI FRISCO MC, LOPEZ R : In vivo biological activity of recombinant Der p II allergen of house-dust mite, Int Arch Allergy Immunol 1994;105:70-4.
27. IWAMOTO N, NISHIYAMA C, YASUHARA T et al. : Direct expression of Der f 2, a major house dust mite allergen, in Escherichia coli. Int Arch Allergy Immunol 1996;109: 356-61.
28. LIN KL, HSIEH KH, THOMAS WR, CHIANG BL, CHUA KY : Characterization of Der p V allergen, cDNA analysis, and IgE-mediated reactivity to the recombinant protein. J Allergy Clin Immunol 1994;94:989-96.
29. CHAPMAN MD, VAILES L, BAVBEK S et coll. Multi-center study of the biologic activity of recombinant group 5 mite allergens. J Allergy Clin Immunol 1997;39:S345 (abstract).
30. SHEN HD, CHUA KY, LIN WL, CHEN HL, HSIEH KH, THOMAS WR : IgE and monoclonal antibody binding by the mite allergen Der p 7. Clin. Exp Allergy 1996;26:308-15.
31. AKI T, KODAMA T, FUJIKAWA A et al. : Immunochemical characterization of recombinant and native tropomyosins as a new allergen from the house dust mite, Dermatophagoides farinae. J Allergy Clin Immunol 1995;96:74-83.
32. ARRUDA K, VAILES LD, PLATTS-MILLS TAE et al. : Sensitization to Blomia tropicalis in patients with asthma and identification of allergen Blo t 5. Am J Respir Crit Care Med 1997;155:343-50.
33. CHAPMAN MD, SMITH AM, VAILES LD, ARRUDA LK : Defined epitopes : in viva and in vitro studies using recombinant allergens, Int Arch Allergy Immunol 1997;113:102-4.
34. ARRUDA LK, VAILES LD, HAYDEN ML, BENJAMIN DC, CHAPMAN MD : Cloning of cockroach allergen, Bla g 4, identifies ligand binding proteins (or calycins) as a cause of IgE antibody responses. J Biol Chem 1995;52:31196-201.
35. MOSER M, CRAMERI R, MENZ G et al. : Cloning and expression of recombinant Aspergillus fumigatus allergen I/a (rAsp f 1/a) with IgE binding and type I skin test activity. J Immunol 1992;149:454-60.
36. CRAMERI R, LIDHOLM J, GRONLUND H, STÜBER D, BLASER K, MENZ G : Automated specific IgE assay with recombinant allergens: evaluation of the recombinant Aspergillus fumigatus allergen I in the Pharmacia CAP System. Clin Exp Allergy 1996;26:1411-9.
37. DE VOUGE MW, THAKER A, CURRAN IHA et al. : Isolation and expression of a cDNA clone encoding an Alternaria alternata Alt a 1 subunit, Int Arch Allergy Immunol 1996;111:285-395.
38. BUSH R, SANCHEZ H, GEISLER D et al. : Recombinant Alt a 2 is a significant Alternaria allergen. J Allergy Clin Immunol 1997;350 Abst.
39. MORGENSTERN JP, GRIFFITH IJ, BRAUER AW et al. : Amino acid sequence of Fel d 1 the major allergen of the domestic cat: protein sequence analysis and cDNA cloning. Proc Natl Acad Sci USA 1991;88:9690-4.
40. ROGERS BL, MORGENSTERN JP, GARMAN RD, BOND JF, KUO MC : Recombinant Fel d 1 : expression, purification, IgE binding and reaction with cat-allergic human T cells. Mol Immunol 1993;30:559-68.
41. GREGOIRE C, ROSINSKI-CHUPIN I, RABILLON J, ALZARI PM, DAVID B, DANDEU JP : cDNA cloning and sequencing reveal the major horse allergen Equ c 1 to be a glycoprotein member of the lipocalin superfamily. J Biol Chem 1996;51:32951-9.
42. ZEILER T, TAIVAINEN A, RYTKONEN M et al. : Recombinant allergen fragments as candidate preparations for allergen immunotherapy. J Allergy Clin Immunol 1997;100:721-7.
43. MOHAPATRA SS : Recombinant allergens and allergen standardization. J Allergy Clin Immunol 1991;87:621-5.
44. VALENTA R, KRAFT D : Recombinant allergens for diagnosis and therapy of allergic diseases. Curr Opin Immunol 1995;7:751-6.
45. VAN NEERVEN RJJ, EBNER C, YSSEL H, KAPSENBERG ML, LAMB JR : T-cell responses to allergens: epitope-specificity and clinical relevance, Immunol Today, 1996;17:526-32.
46. NORMAN PS, OHMAN JL, LONG A, CRETICOS PS et al. : Treatment of cat allergy with T-cell reactive peptides. Am J Respir Crit Care Med 1996;154:1623-8.
47. EBNER C, FERREIRA F : Hypoallergenic isoform variants of allergens. A new concept for specific immunotherapy. ACI International 1997;9:69-71.
48. FERREIRA F, HIRTHENLEHNER K, JILEK A et al. : Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1 : Potential use of hypoallergenic isoforms for immunotherapy. J Exp Med 1996;183:599-609.
49. SMITH AM, CHAPMAN MD : Reduction in IgE binding to allergen variants generated by site-directed mutagenesis : contribution of disulfide bonds to the antigenic structure of the major house dust mite allergen, Der p 2. Mol Immunol 1996;33:399-405.
50. TAKAI T, YOKOTA T, YASUE M et al. : Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy. Nature Biotechology 1997;15:754-8.
51. BUFE A, BECKER WM, SCHRAMM G, PETERSEN A, MAMAT U, SCHLAAK M : Major allergen PhI p Va (timothy grass) bears at least two different IgE-reactive epitopes. J Allergy Clin Immunol 1994;94:173-81.
52. SCHRAMM G, BUFE A, PETERSEN A, HAAS H, SCHLAAK M, BECKER WM : Mapping of IgE-binding epitopes on the recombinant major group I allergen of velvet grass pollen rHol I 1. J Allergy Clin Immunol 1997;99:781-7.
53. VRTALA S, HIRTENLEHNER K, VANGELISTA L et al. : Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope - Containing fragments candidates for a novel form of specific immunotherapy. J Clin Invest 1997;99:1673-81.